Beta Drugs Ltd.

View in App
1345.00 ▼0%

25 April 2024, 03:55:22 PM

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.betadrugslimited.com
Market Cap 1,320.93 Cr.
Enterprise Value(EV) 1,323.89 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 31.95 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 43.00 Trailing Twelve Months Ending 2023-03
Industry PE 41.74 Trailing Twelve Months Ending 2023-03
Book Value / Share 127.82 Trailing Twelve Months Ending 2023-03
Price to Book Value 10.75 Calculated using Price: 1,374.00
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.96 Cr. 9,613,790 Shares
FaceValue 10
About Beta Drugs Ltd.
Beta Drugs is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases. Beta Drugs is a part of Adley Group, which was founded in the year 1985. Company's manufacturing unit is located at Solan, Himachal Pradesh.

Beta Drugs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Beta Drugs Ltd. Performance

View details >>
1 Day
1 Week
-2.53%
1 Month
+8.03%
3 Month
-2.32%
6 Month
+46.71%
1 Year
+76.97%
2 Year
+103.79%
5 Year
+1192.65%
10 Year

Beta Drugs Ltd. Fundamental Ratios

View details >>
6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 20.57 21.79 19.21 18.65 30.85 28.55
Return on Capital Employed (%) 19.36 18.41 20.71 22.17 36.38 33.94
Return on Assets (%) 13.64 12.1 9.82 10.26 17.53 16.74

Beta Drugs Ltd. Balance Sheet

View details >>
Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 33 41 57 69 92 123 142
Non Curr. Liab. 3 9 13 15 16 11 11
Curr. Liab. 14 33 38 37 55 70 83
Minority Int.
Equity & Liab. 50 83 108 120 163 204 236
Non Curr. Assets 17 39 51 49 60 70 72
Curr. Assets 32 44 57 71 103 134 164
Misc. Exp. not W/O
Total Assets 50 83 108 120 163 204 236

Beta Drugs Ltd. Profit and Loss

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 51 66 91 116 184 227
Other Income 0 0 0 1 1 1
Total Income 51 66 91 117 185 228
Total Expenditure -41 -54 -73 -91 -141 -174
PBIDT 10 12 18 25 43 54
Interest -1 -1 -3 -2 -2 -2
Depreciation -2 -3 -4 -7 -7 -10
Taxation 0 0 -3 -4 -9 -10
Exceptional Items
PAT 7 8 9 12 25 31
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 7 8 9 12 25 31
Adjusted EPS 8 9 10 12 26 32

Beta Drugs Ltd. Cash Flow

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 17 0 8 19 30 23
Cash Fr. Inv. -11 -21 -15 -6 -22 -19
Cash Fr. Finan. 5 12 9 -8 -1 -2
Net Change 12 -9 2 5 7 2
Cash & Cash Eqvt 12 3 5 10 17 19

Beta Drugs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 66.71 66.71 66.71 66.71 66.73 66.73 66.73 66.73 66.73
Public 33.29 33.29 33.29 33.29 33.27 33.26 33.27 33.26 33.27
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Beta Drugs Ltd. Announcements

View details >>
Tue, 09 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Beta Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Fri, 29 Mar 2024
Trading Window-XBRL
BETA DRUGS LIMITED has informed the Exchange about Closure of Trading Window
Fri, 29 Mar 2024
Trading Window
Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Beta Drugs Ltd. Technical Scans

View details >>
Thu, 25 Apr 2024
Opening at High Opening at High
High Increase in 1 Month High Increase in 1 Month
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years

Beta Drugs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,521.45 +0.1%
Cipla Ltd. 113,471.29 1,411.10 +0.4%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,228.35 +0.2%
Divi's Laboratories Ltd. 101,959.84 3,925.50 +2.1%
Zydus Lifesciences Ltd. 95,944.41 955.65 +0.5%
Mankind Pharma Ltd. 95,926.91 2,391.45 -0.3%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,332.35 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,521.45 +0.1%
Cipla Ltd. Consolidated 2023-12 30.60 1,411.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,228.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 3,925.50 +2.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 955.65 +0.5%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,391.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,332.35 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,521.45 +0.1%
Cipla Ltd. Consolidated 2023-12 4.38 1,411.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,228.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 3,925.50 +2.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 955.65 +0.5%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,391.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,332.35 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,521.45 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,411.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,228.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,925.50 +2.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 955.65 +0.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,391.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,332.35 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,521.45 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,411.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,228.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,925.50 +2.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 955.65 +0.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,391.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,332.35 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,521.45 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,411.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,228.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,925.50 +2.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 955.65 +0.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,391.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,332.35 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,521.45 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,411.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,228.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,925.50 +2.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 955.65 +0.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,391.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,332.35 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,521.45 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,411.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,228.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,925.50 +2.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 955.65 +0.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,391.45 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,332.35 -0.8%

Beta Drugs Ltd. FAQ's

What is Beta Drugs share price?
Can I buy Beta Drugs shares now?
What is the Market Cap of Beta Drugs?
What are the key metrics to analyse Beta Drugs?
What is the 52 Week High and Low of Beta Drugs?